IRIS
COSTANTINI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.763
EU - Europa 1.446
AS - Asia 450
AF - Africa 34
OC - Oceania 23
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.719
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.763
IT - Italia 299
UA - Ucraina 292
SE - Svezia 244
IE - Irlanda 179
CN - Cina 175
SG - Singapore 150
DE - Germania 141
DK - Danimarca 96
GB - Regno Unito 66
TR - Turchia 60
FR - Francia 57
FI - Finlandia 50
KR - Corea 50
AU - Australia 23
CI - Costa d'Avorio 21
BE - Belgio 11
MA - Marocco 11
IN - India 7
JP - Giappone 4
NL - Olanda 4
AE - Emirati Arabi Uniti 2
AT - Austria 2
CH - Svizzera 2
CO - Colombia 2
RO - Romania 2
TH - Thailandia 2
EU - Europa 1
NG - Nigeria 1
PL - Polonia 1
TN - Tunisia 1
Totale 4.719
Salva come PNG Salva come JPEG
Città #
Chandler 376
Jacksonville 317
Fairfield 247
Boardman 187
Dublin 177
Ashburn 149
Wilmington 140
Des Moines 123
Woodbridge 112
Seattle 89
Ann Arbor 85
New York 78
San Mateo 73
Houston 71
Lawrence 71
Princeton 71
Redmond 58
Cambridge 49
Singapore 48
San Diego 40
Centro 38
Rome 29
Beijing 27
Ancona 23
Abidjan 21
Marche 21
Turin 16
Guangzhou 15
London 15
Melbourne 15
Istia D'ombrone 12
Norwalk 12
Brussels 11
Washington 11
Wuhan 10
Civitanova Marche 9
Los Angeles 9
Porto 9
Shanghai 9
Chiaravalle 8
Kingscliff 8
Quanzhou 7
Mcallen 6
Wuxi 6
Charlotte 5
Florence 5
Helsinki 5
Pune 5
Auburn Hills 4
Bristol 4
Castelfiorentino 4
Falls Church 4
Kilburn 4
Milan 4
Nanjing 4
Weihai 4
Bologna 3
Dalian 3
Dallas 3
Falconara Marittima 3
Hounslow 3
Istanbul 3
Jiaxing 3
Napoli 3
Perugia 3
Shenzhen 3
Taranto 3
Torre Annunziata 3
Vallefoglia 3
Zibo 3
Acton 2
Bangkok 2
Bogotá 2
Boydton 2
Cedar Knolls 2
Frankfurt am Main 2
Hanover 2
Izmir 2
Jinan 2
Kingsland 2
Miami 2
Montespertoli 2
New Bedfont 2
Nocera Superiore 2
Nuremberg 2
Nürnberg 2
Pescara 2
Prescot 2
Stroudsburg 2
Vienna 2
Zurich 2
Amandola 1
Bari 1
Bollengo 1
Caserta 1
Chengdu 1
Chicago 1
Chiswick 1
Corridonia 1
Dongyang 1
Totale 3.053
Salva come PNG Salva come JPEG
Nome #
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 101
null 100
Response to: Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev” by Eugenia Quiros-Roldan, Giorgio Biasiotto and Isabella Zanella 100
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 98
Higly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations 97
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI. 96
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. 96
Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individuals 94
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 88
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 87
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy 87
Effects of cryopreservation on lymphocyte immunophenotype and function 85
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 85
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 85
Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. 82
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort. 81
Il ruolo del Medico di Medicina Generale nella diagnosi precoce della malattia da HIV. 80
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 79
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 79
Specific changes in the post-translational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus 76
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 74
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 73
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting. 72
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50cp/mL. 70
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy. 69
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study. 69
Genotypic Resistance Tests for the Management of Structured Therapeutic Interruptions after Multiple Drug Failure: Prosecution 67
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 67
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV. 65
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 63
CROI 2013: le ricadute per la pratica clinica. 63
Efficacy and costs of Direct Acting Antivirals (DAAS) for the treatment of HCV Iinfection amnog HCV-monoinfected and HIV/HCV co-infected patients in real-life setting 63
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 63
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 62
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 62
Lo studio fenotipico di linfociti e altre cellule mononucleate. 60
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. 60
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 60
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study. 60
PROGETTO E-PROs: COSTRUZIONE DI UNA PIATTAFORMA DIGITALE PER LA GESTIONE DI STRUMENTI CENTRATI SUL PAZIENTE NELLA PRATICA CLINICA (The E-PROs Project: creation of a digital platform to manage patient-oriented tools in clinical practice). 60
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 59
Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche. 58
HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy 58
Do we still need CD4 T cell count? 58
Direct acting antivirals (DAAs) for the treatment of HCV infection in HIV/HCV coinfected patients: a clinical experience. 58
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014. 58
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio 57
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 56
Day-On, Day-Off emtricitabine, tenofovir disoproxil fumarate and efavirenz single tablet regimen (DODO) as maintenance therapy in HIV-infected patients 56
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 55
Il paziente adulto con immunodeficienza. 53
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 53
The effect of dupilumab in an HBV-HIV coinfected atopic patient: a case report 53
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. 52
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 52
Validation of a self-reported HIV symptoms list: the ISS-HIV symptoms scale. 52
Diagnostica immunologica. 52
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 51
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 50
Polyclonal serum-free light chains elevation in HIV-infected patients. 49
LA SIEROLOGIA TIPO-SPECIFICA PER HERPES SYMPLEX TIPO 2 NELLA GESTIONE DEI PAZIENTI HIV POSITIVI 49
La ricerca degli anticorpi anti-nucleo non è sempre di facile interpretazione 49
Soluble CD163 in CMV Infected and Uninfected subjects on Virologically-Suppressive Antiretroviral therapy in the ICONA cohort 47
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV. 46
Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort 45
Infezione da HIV-1. 43
Il ruolo del Mmg nella diagnosi precoce della malattia da HIV. 42
Switch a raltegravir in un paziente con carcinoma a cellule di Merkel e sarcoma di Kaposi. 39
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 38
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina. 38
La tollerabilità della terapia antiretrovirale come mezzo per la gestione a lungo termine di pazienti complessi: un caso clinico. 38
HIV among adolescents and young adults in Italy: focus on epidemiological, viro-immunological and treatment characteristics of 689 18-24 year old subjects enrolled in the ICONA Cohort. 38
L’immunoricostituzione, un paesaggio dai mutevoli confini 37
Characterisation and outcomes of difficult-to-treat patients in an Italian cohort of PLWHIV starting modern ART regimens. 36
La riduzione delle interazioni farmacologiche come mezzo per aumentare l’aderenza alla terapia antiretrovirale e garantirne la durability. 28
PRIMARY BILIARY CHOLANGITIS CASE- FINDING: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY ON PATIENTS WITH INCIDENTAL FINDING OF ANTI- MITOCHONDRIAL ANTIBODIES. 21
Specific Anti-Nuclear Antibodies, Clinical Features and Outcome Following Treatment with Nilotinib In Patients with Chronic Graft-Versus-Host Disease. The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Sessions 17
Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort 11
OC-43 ‘U=U impossibile sbagliare’ awareness campaign: impact assessment among PLWH 9
OC-34 Clinical outcome of switching to a dual drug regimen (2DR) vs. switching or remaining on a triple (3DR) regimen in the setting of a viral load ≤50 copies/mL 7
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 4
Management of vaccinations in patients with non‐Hodgkin lymphoma 3
Totale 4.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020383 0 0 0 6 70 52 63 5 70 13 14 90
2020/20211.058 71 105 129 13 123 44 95 63 126 93 122 74
2021/2022585 37 129 12 34 8 31 30 52 43 48 58 103
2022/20231.153 107 121 75 118 79 230 0 61 277 4 50 31
2023/2024656 105 11 31 85 133 125 18 17 12 13 15 91
2024/2025365 199 110 56 0 0 0 0 0 0 0 0 0
Totale 4.853